Stephanie Smith–Marrone

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes

Jarushka Naidoo, Maria L. Santos-Zabala, Tunç Iyriboz et al. · Clinical Lung Cancer · 2016 · 162 citations · Full text

Medicine, Oncology, Surgery +14

Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC).

Catherine A. Shu, Claud Grigg, Codruța Chiuzan et al. · Journal of Clinical Oncology · 2018 · 46 citations

Medicine, Oncology, Pharmacology +15

A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m²for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Matthew G. Fury, Eric J. Sherman, Donna Lisa et al. · Journal of the National Comprehensive Cancer Network · 2012 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity‐modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma

Matthew G. Fury, Han Xiao, Eric J. Sherman et al. · Head & Neck · 2015 · 40 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer

Shrujal S. Baxi, Talya Salz, Han Xiao et al. · Cancers of the Head & Neck · 2016 · 34 citations · Full text

Medicine, Oncology, Radiation Oncology +15